00:50:30 EST Fri 14 Dec 2018
Enter Symbol
or Name
USA
CA



T:ONC - ONCOLYTICS BIOTECH INC. - http://www.oncolyticsbiotech.com00:50:30 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ONC - T  3.12.75 · 3.051.12.76-0.21-7.119.7581323.01  3.01  2.7510.65  2.6015:59:52Dec 1215 min RT 2¢
TSX - T3.12.75 · 3.051.12.75-0.22-7.418.2541223.01  3.01  2.7510.65  2.6015:59:5215 min
CX2 - H 2.83-0.14-4.70.2022.83  2.83  2.8311:37:5315 min
Pure - P 2.76-0.21-7.10.2122.76  2.76  2.7615:59:5215 min
Omega - O 2.92-0.05-1.70.2112.92  2.92  2.9211:31:4115 min
TriAct - M 2.970.213    Dec 12 09:45:3515 min
Aequitas NEO - U 2.83-0.14-4.70.8222.90  2.90  2.8313:19:5015 min

Recent Trades - Last 10 of 132
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:52P2.76-0.211001 Anonymous79 CIBCK
15:59:52T2.76-0.211002 RBC1 AnonymousK
15:59:52T2.76-0.216002 RBC79 CIBCK
15:59:52T2.75-0.222002 RBC79 CIBCK
15:59:52T2.75-0.221002 RBC79 CIBCK
15:59:52T2.75-0.221002 RBC1 AnonymousK
15:59:52T2.75-0.221002 RBC1 AnonymousK
15:59:29T2.78-0.191001 Anonymous7 TD SecK
15:59:29T2.78-0.191001 Anonymous7 TD SecK
15:59:29T2.78-0.1910039 Merrill Lynch7 TD SecK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolExPriceTypeHeadline
2018-12-12 07:20C:ONC2.75News ReleaseOncolytics treats first patient in pelareorep study
2018-12-03 08:04C:ONC3.50News ReleaseOncolytics's pelareorep subject of poster presentation
2018-11-29 08:25C:ONC3.44News ReleaseOncolytics appoints Laeufle chief medical officer
2018-11-26 09:36C:ONC3.20News ReleaseOncolytics treats 1st patient with pelareorep/Keytruda